Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

Clinical trial NCT02101879 · UNKNOWN

Trial details

NCT number: NCT02101879
Sponsor: Rambam Health Care Campus
Status: UNKNOWN
Study type: OBSERVATIONAL

Cardiotoxicity.Anti Her2 Therapy.Metastatic Breast Cancer

Start date: 2014-05-01
Primary completion: 2016-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.